The efficacy of Nano-crystalline hydroxyapatite combined with parathyroid hormone versus Nano-crystalline hydroxyapatite alone on healing of bone defect after cyst enucleation: a randomized clinical trial (RCT) | ||
| Egyptian Dental Journal | ||
| Volume 70, Issue 4 - Serial Number 2, October 2024, Pages 3193-3201 PDF (1.29 M) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/edj.2024.315328.3177 | ||
| Authors | ||
| Rofaida A. Abaas* 1; Arwa Mousa2; Heba M. Kamel3; Nahla Mahmoud Awadallah1 | ||
| 1Lecturer Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Cairo University, Cairo, Egypt | ||
| 2Lecturer Oral and Maxillofacial Radiology Department, Faculty of Dentistry, Cairo University, Cairo, Egypt | ||
| 3Assistant professor Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Cairo University, Cairo, Egypt. | ||
| Abstract | ||
| Objective: This study aimed at evaluation clinical and radiographic efficacy of using Nano-crystalline hydroxyapatite combined with parathyroid hormone versus Nano-crystalline hydroxyapatite only on healing of bone defects after cyst enucleation. Methods: 20 patients with bone defects were included, they were equally allocated in two groups; intervention group (group I) where the defect was filled with Nano-crystalline hydroxyapatite (Nano-bone®) combined with parathyroid hormone (PTH 1-34) and control group (group II) where the defect was filled with Nano-crystalline hydroxyapatite alone (Nano-bone®). Surgical procedure was made under local or general anesthesia. Radiographic assessment using cone beam computed tomography (CBCT) was performed to measure defect size (preoperative and six months post-operatively). Results: There weren’t post-operative complications. Radiographically, in intervention group, average defect dimensions 2.8 ± 0.41 cm3 preoperatively, 3.88 ± 0.55 cm3 immediately postoperatively, and 1.20 ± 0.15 cm3 six months postoperatively. Meanwhile, in group II, they were 2.2 ± 0.33 cm3 preoperatively, 2.5 ± 0.3 cm3 immediately postoperatively and 1.5 ± 0.4 cm3 six months postoperatively with a significant difference between both groups (< 0.001). Moreover, the average dimensions of the graft surface area, in group I were 144.52 ± 14.78 mm² preoperatively, and 86.56 ± 15.57 mm2 six months postoperatively. While in group II the measurements were 152.62 ± 12.78 mm² preoperatively, and 100.54 ± 13.57 mm2 six months postoperatively with a significant difference between both groups (< 0.001). Conclusion: Using the combination of Nano-crystalline hydroxyapatite combined with parathyroid hormone has a positive impact on healing of bone defect after cyst enucleation. | ||
| Keywords | ||
| Nano-Crystalline Hydroxyapatite; Parathyroid Hormone; bone defect; CBCT | ||
|
Statistics Article View: 194 PDF Download: 131 |
||
